{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "MSEPO-21206 Safe handling of medicines policy.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 16,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document title:"
                    },
                    {
                        "text": "SAFE HANDLING OF MEDICINES POLICY"
                    },
                    {
                        "text": "Document reference/register no:"
                    },
                    {
                        "text": "MSEPO-21206"
                    },
                    {
                        "text": "Version number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP/CCP)"
                    },
                    {
                        "text": "Policy"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All staff involved in the prescribing, supply and administration of medicines"
                    },
                    {
                        "text": "Ratification issue date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "07 December 2021"
                    },
                    {
                        "text": "Review date:"
                    },
                    {
                        "text": "06 December 2024"
                    },
                    {
                        "text": "Key word(s) to search for document on intranet:"
                    },
                    {
                        "text": "Medication, medicines, transport, delivery, potassium, cytotoxic, cytostatic, waste, stationary"
                    },
                    {
                        "text": "Developed in response to: (National guidance/recommendations (i.e. NICE; RCOG)"
                    },
                    {
                        "text": "NPSA (2002). PSA: Potassium solutions: Risks to patients from errors during intravenous administration"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Care group/division:"
                    },
                    {
                        "text": "Division 9"
                    },
                    {
                        "text": "Pharmacy"
                    },
                    {
                        "text": "Author/contact: (asset administrator)"
                    },
                    {
                        "text": "Richard Ketley"
                    },
                    {
                        "text": "Principal Pharmacist Medication Safety and MSO"
                    },
                    {
                        "text": "Hospital sites: (tick appropriate box(s) to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2612 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2610 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Approval group/ committee(s):"
                    },
                    {
                        "text": "Medicines Assurance Group Chair action A.Kabir"
                    },
                    {
                        "text": "30 November 2021"
                    },
                    {
                        "text": "Professionally approved by: (Asset Owner)"
                    },
                    {
                        "text": "Evelyn Allen"
                    },
                    {
                        "text": "Chief Pharmacist"
                    },
                    {
                        "text": "30 November 2021"
                    },
                    {
                        "text": "Ratification group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "07 December 2021"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Executive and clinical directors (Communication of minutes from Joint Document Management Group)"
                    },
                    {
                        "text": "January 22"
                    },
                    {
                        "text": "Distribution method:"
                    },
                    {
                        "text": "\u2612 Trust Intranet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "MSEPO-21206 Safe handling of medicines policy.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 10,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted with: (Must include specialist pharmacists if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Simon Worrall"
                    },
                    {
                        "text": "Deputy Chief Pharmacist"
                    },
                    {
                        "text": "29 November 2021"
                    },
                    {
                        "text": "David Jeffries"
                    },
                    {
                        "text": "Head of Quality, Pharmacy Quality Assurance"
                    },
                    {
                        "text": "29 November 2021"
                    },
                    {
                        "text": "Alison Felton"
                    },
                    {
                        "text": "Pharmacy Head of Department, Broomfield"
                    },
                    {
                        "text": "29 November 2021"
                    },
                    {
                        "text": "Fatemeh Leedham"
                    },
                    {
                        "text": "Pharmacy Head of Department, Basildon"
                    },
                    {
                        "text": "29 November 2021"
                    },
                    {
                        "text": "Tomi Tommy-Uffang"
                    },
                    {
                        "text": "Pharmacy Head of Department, Southend"
                    },
                    {
                        "text": "29 November 2021"
                    },
                    {
                        "text": "Nina Webb"
                    },
                    {
                        "text": "Pharmacy Operations Manager, Basildon"
                    },
                    {
                        "text": "29 November 2021"
                    },
                    {
                        "text": "Katy Mason"
                    },
                    {
                        "text": "Pharmacy Operations Manager, Broomfield"
                    },
                    {
                        "text": "29 November 2021"
                    },
                    {
                        "text": "Niki Gibson"
                    },
                    {
                        "text": "Pharmacy Operations Manager, Southend"
                    },
                    {
                        "text": "29 November 2021"
                    },
                    {
                        "text": "Chris Overland"
                    },
                    {
                        "text": "Pharmacy Business Manager"
                    },
                    {
                        "text": "29 November 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 2,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Post/ Approval Committee/ Group: (Must include Medication Assurance Group if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Medicines Assurance Group - Chair action A.Kabir"
                    },
                    {
                        "text": "30 November 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust documents (to be read in conjunction with)"
                    },
                    {
                        "text": "(Refer to the main body of the text) Courier and taxi policy or equivalent MSEPO-20237 Controlled drugs policy MSBPO-18017 Unlicensed medicines policy MSEPO-20205 Safe and secure storage of medicines in clinical areas MSEPO-21130 Medical gases operational policy and procedure for the safe management and use MSEPO-20204 Safe handling effective use and management of IMPs policy Prescribing of medicines policy or equivalent MSEPO-21005 FP10 Prescription policy and procedure MSEPO-21187 Order and supply of paper hospital-only outpatient prescriptions MSEPO- 21087 Dealing with pharmaceutical company representatives and drug samples policy MSEPO-21128 Administration of medicines policy. MSEPO-21088 Management of IntraTHECAL chemotherapy policy MSEPO-21144 Discharge TTA medication policy MSEPO-20218 Control of substances hazardous to health (COSHH) policy MSEPO-21112 Waste management policy and procedure Safe prescribing, handling and administration of systemic anticancer therapy policy"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 7,
            "data": {
                "num_rows": 5,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document review history:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ record documents superseded by:"
                    },
                    {
                        "text": "Issue date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Richard Ketley"
                    },
                    {
                        "text": "07 December 2021"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Contents"
            },
            "type": "ListItem",
            "sequence_num": 8
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Introduction ................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Scope ........................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.0,
                "text": "Definitions ..................................................................................................................... 5"
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "Role and responsibilities within the Trust ...................................................................... 6"
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "Controlled stationery and prescription charts or forms.................................................. 9"
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "Procurement, acquisition and recall of medicines by pharmacy ................................. 10"
            },
            "type": "ListItem",
            "sequence_num": 14
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.0,
                "text": "Manufacturing and manipulation of medicines ............................................................ 11"
            },
            "type": "ListItem",
            "sequence_num": 15
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.0,
                "text": "Injectable medicines handling ..................................................................................... 12"
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 24.0,
                "text": "Receipt of medicines .................................................................................................. 13  Security of medicines within pharmacy ....................................................................... 13  Storage of medicines within pharmacy ....................................................................... 14  Ordering medicines from pharmacy ............................................................................ 14  Dispensing or supply to point of use ........................................................................... 16  Transportation of medicines ....................................................................................... 17  COSHH requirements ................................................................................................. 19  Strong potassium solution (potassium chloride concentrate solution) ........................ 19  Cytotoxic medicines .................................................................................................... 22  Managing waste and unwanted medicines within clinical areas ................................. 23  Community nursing and midwifery .............................................................................. 25  Training requirements ................................................................................................. 26  Monitoring and audit ................................................................................................... 26  Approval and implementation ..................................................................................... 26  Preliminary equality analysis ...................................................................................... 26  References ................................................................................................................. 27 Appendix 1: Preliminary equality analysis .......................................................................... 28"
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            },
            "type": "ListItem",
            "sequence_num": 18
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "\u2018Medicines are used in all healthcare settings and the safe and secure handling of medicines is essential to ensure patient safety' (RPS, 2018)."
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "Persons authorised to handle medicines anywhere in our organisation are accountable and must comply with legal and registration frameworks, professional guidance and/or organisational or relevant national policy requirements (RPS, 2018)."
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.3,
                "text": "The specific requirements of specialist clinical areas may not be covered in this document and these may necessitate more detailed local procedures. These are the responsibility of the relevant division and speciality and such procedures may need approval by the department of pharmacy before implementation."
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.4,
                "text": "Any contract for services to be provided to the Trust which may require the contractor's employee to handle medicines, shall specify the right of the Chief Pharmacist to ensure satisfactory recruitment and selection criteria for such employees is made."
            },
            "type": "ListItem",
            "sequence_num": 22
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            },
            "type": "ListItem",
            "sequence_num": 23
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "The purpose of this document is to:"
            },
            "type": "ListItem",
            "sequence_num": 24
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Outline the processes associated with the handling of medicines. These include obtaining medicines, their transport, receipt, manufacture or manipulation, issuing of medicines, and their removal or disposal."
            },
            "type": "ListItem",
            "sequence_num": 25
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The storage of medicines within pharmacy is outlined within this policy and pharmacy departmental procedures."
            },
            "type": "ListItem",
            "sequence_num": 26
        },
        {
            "data": {
                "is_heading": 1,
                "text": "For the storage of medicines in clinical areas please refer to MSEPO-20205 Safe and Secure Storage of Medicines in Clinical Areas."
            },
            "type": "ListItem",
            "sequence_num": 27
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.2,
                "text": "This policy does not cover some specific medication types. The following documents should be referred to:"
            },
            "type": "ListItem",
            "sequence_num": 28
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Unlicensed medicines: For medicines without a UK marketing authorisation refer to MSBPO-18017 Unlicensed Medicines Policy."
            },
            "type": "ListItem",
            "sequence_num": 29
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Controlled Drugs and unidentifiable substances (that may or may not be illicit): refer to refer to MSEPO-20237 Controlled Drugs Policy."
            },
            "type": "ListItem",
            "sequence_num": 30
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Medical gases are licensed medical products and should be prescribed, used and stored as medicines. Refer to MSEPO-21130 Medical gases operational policy and procedure for the safe management and use."
            },
            "type": "ListItem",
            "sequence_num": 31
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Investigational Medicinal Products must always be prescribed. Often these are prescribed as the clinical trial in which they are authorised for use. Refer to MSEPO-20204 Safe Handling Effective Use and Management of IMPs Policy."
            },
            "type": "ListItem",
            "sequence_num": 32
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Non-formulary medicines are not approved for use in the Trust and therefore not listed in the Trust formulary. Refer to Prescribing of Medicines Policy. Requests must be referred to the site clinical lead pharmacist or deputy."
            },
            "type": "ListItem",
            "sequence_num": 33
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.3,
                "text": "Pharmacy department manufacturing and quality follow the Rules and Guidance for Pharmaceutical Manufacturing from the MHRA. They follow the principles of this policy but have a separate pharmaceutical quality management system that whilst governed by the Trust is licensed by the MHRA."
            },
            "type": "ListItem",
            "sequence_num": 34
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions"
            },
            "type": "ListItem",
            "sequence_num": 35
        },
        {
            "type": "table",
            "sequence_num": 36,
            "data": {
                "num_rows": 11,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Term"
                    },
                    {
                        "text": "Definition"
                    },
                    {
                        "text": "Bounty Bag"
                    },
                    {
                        "text": "Distributed by hospital staff to new mothers during their stay in hospital after the birth of their baby. It contains information and product samples."
                    },
                    {
                        "text": "Controlled Stationery"
                    },
                    {
                        "text": "In context of this policy: any stationery which, in the wrong hands, could be used to obtain medicines fraudulently. This stationery includes FP10s, out-patient, discharge and in- patient prescriptions; Controlled Drugs and other Trust medicines requisition stationery."
                    },
                    {
                        "text": "FP10"
                    },
                    {
                        "text": "In context of Trust-usage these are green paper prescriptions that can be dispensed by any community pharmacy."
                    },
                    {
                        "text": "Medicine"
                    },
                    {
                        "text": "\u2018Medicinal product' defined under Medicines Act 1968: That is, any substance administered for treating, preventing or diagnosing disease, for contraception, for inducing anaesthesia or modifying a normal physiological function. Medical gases are medicinal products."
                    },
                    {
                        "text": "Pharmacist Clinical Screen / verification"
                    },
                    {
                        "text": "This is a check of a patient's prescription to ensure the appropriateness of all medication prescribed e.g. indications, co-morbidities, doses, interactions, route of administration, formulations, appropriate monitoring. This is in accordance with specific pharmacy departmental procedures."
                    },
                    {
                        "text": "Potassium chloride concentrate solution"
                    },
                    {
                        "text": "Any potassium chloride-containing injection greater than 10% strength of potassium chloride; presented in ampoules or vials."
                    },
                    {
                        "text": "STAT"
                    },
                    {
                        "text": "Once only, give immediately."
                    },
                    {
                        "text": "Topping up"
                    },
                    {
                        "text": "Process where pharmacy staff visit clinical areas to compare actual stocks of medicines against an agreed stock list. A supply of medicines is provided to restore the stock holding to the agreed stock levels."
                    },
                    {
                        "text": "TTA / TTO"
                    },
                    {
                        "text": "To take away / To take out \u2013 these interchangeable terms refer to prescribed discharge medication."
                    },
                    {
                        "text": "ePMA"
                    },
                    {
                        "text": "Electronic prescribing and medicines administration."
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Role and responsibilities within the Trust"
            },
            "type": "ListItem",
            "sequence_num": 37
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "MSE Quality Governance Group (QGG)"
            },
            "type": "ListItem",
            "sequence_num": 38
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Receiving exception reports and taking action in response to issues raised from Medicines Assurance Group and/or department of pharmacy."
            },
            "type": "ListItem",
            "sequence_num": 39
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.2,
                "text": "MSE Medicines Assurance Group (MAG)"
            },
            "type": "ListItem",
            "sequence_num": 40
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring the effective implementation, use and timely review of this policy;"
            },
            "type": "ListItem",
            "sequence_num": 41
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that monitoring arrangements are appropriately performed by the Medicines Optimisation and Safety Group (MOSG);"
            },
            "type": "ListItem",
            "sequence_num": 42
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Approving and reviewing mechanisms for medicines optimisation in line within its terms of reference;"
            },
            "type": "ListItem",
            "sequence_num": 43
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Where necessary, escalating concerns to the Chief Nurse and site Director of Nursing or Chief Medical Officer and site Medical Directors as appropriate;"
            },
            "type": "ListItem",
            "sequence_num": 44
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Exception reporting to the MSE Quality Governance Group on developments, concerns and progress concerning safe handling of medicines."
            },
            "type": "ListItem",
            "sequence_num": 45
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.3,
                "text": "Medicines Optimisation and Safety Group (MOSG)"
            },
            "type": "ListItem",
            "sequence_num": 46
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Monitoring this policy through incident reports;"
            },
            "type": "ListItem",
            "sequence_num": 47
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Escalating issues to site divisional governance groups and MAG as appropriate."
            },
            "type": "ListItem",
            "sequence_num": 48
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.4,
                "text": "Department of Pharmacy"
            },
            "type": "ListItem",
            "sequence_num": 49
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Safe and effective procurement of all medicines to be used in the Trust;"
            },
            "type": "ListItem",
            "sequence_num": 50
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Stock of medicines held in the Pharmacy, their manipulation and preparation into ready to use presentations and for their supply to clinical areas."
            },
            "type": "ListItem",
            "sequence_num": 51
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.5,
                "text": "Chief Executive"
            },
            "type": "ListItem",
            "sequence_num": 52
        },
        {
            "data": {
                "is_heading": 0,
                "text": "As the Trust's accountable officer has overall responsibility for ensuring the Trust has robust, complete and up to date documents in place to govern and guide activities so that legal and national requirements are met."
            },
            "type": "ListItem",
            "sequence_num": 53
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.6,
                "text": "Chief Medical Officer"
            },
            "type": "ListItem",
            "sequence_num": 54
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that there is policy compliance and liaising with the site Medical Directors that the service is operating effectively;"
            },
            "type": "ListItem",
            "sequence_num": 55
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring sufficient resources are in place to implement this policy;"
            },
            "type": "ListItem",
            "sequence_num": 56
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any escalated safe handling of medicines issues involving professions they oversee are appropriately managed corporately;"
            },
            "type": "ListItem",
            "sequence_num": 57
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.7,
                "text": "Chief Pharmacist"
            },
            "type": "ListItem",
            "sequence_num": 58
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Setting the overall framework and policy standards for safe handling of medicines across the organisation, in line with regulatory and best practice guidance;"
            },
            "type": "ListItem",
            "sequence_num": 59
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring a monitoring process exists and functions for policy standards;"
            },
            "type": "ListItem",
            "sequence_num": 60
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Agreeing suitable recruitment and selection procedures, where required, with those managers responsible for employing staff who may handle medicines in the course of their duties;"
            },
            "type": "ListItem",
            "sequence_num": 61
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Advising managers on training programmes for all persons who handle medicines whilst engaged on Trust business;"
            },
            "type": "ListItem",
            "sequence_num": 62
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.7.1 As the Trust's named Accountable officer for controlled drugs they are responsible for ensuring that effective controls are in place for the storage and security of controlled drugs including handling and usage. Refer to MSEPO-20237 Controlled Drugs Policy."
            },
            "type": "ListItem",
            "sequence_num": 63
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.7.2 The Chief Pharmacist delegates day-to-day responsibility to the site pharmacy Heads of Department and divisional principal clinical lead pharmacists for delivery."
            },
            "type": "ListItem",
            "sequence_num": 64
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.8,
                "text": "Site and divisional Medical Directors"
            },
            "type": "ListItem",
            "sequence_num": 65
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that there is policy compliance on site by all professions they oversee and that the service is operating effectively;"
            },
            "type": "ListItem",
            "sequence_num": 66
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any escalated safe handling of medicines issues involving professions they oversee are appropriately managed corporately."
            },
            "type": "ListItem",
            "sequence_num": 67
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.9,
                "text": "Chief Nursing Officer"
            },
            "type": "ListItem",
            "sequence_num": 68
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that there is policy compliance and liaising with the Chief and Deputy Chief Pharmacist, site Pharmacy Head/s of Department and MSE Medication Safety Officer that the service is operating effectively;"
            },
            "type": "ListItem",
            "sequence_num": 69
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring sufficient resources are in place to implement this policy;"
            },
            "type": "ListItem",
            "sequence_num": 70
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any escalated safe handling of medicines issues involving professions they oversee are appropriately managed corporately."
            },
            "type": "ListItem",
            "sequence_num": 71
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "Site Director of Nursing / Deputy Directors of Nursing / Director of Midwifery"
            },
            "type": "ListItem",
            "sequence_num": 72
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that there is policy compliance on site by all professions they oversee and that the service is operating effectively;"
            },
            "type": "ListItem",
            "sequence_num": 73
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any escalated safe handling of medicines issues involving professions they oversee are appropriately managed corporately;"
            },
            "type": "ListItem",
            "sequence_num": 74
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring sufficient resources are in place to implement this policy."
            },
            "type": "ListItem",
            "sequence_num": 75
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.11,
                "text": "Matron (or Allied Health Professional AHP equivalent) and Ward/Department Manager"
            },
            "type": "ListItem",
            "sequence_num": 76
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that medicine control systems and procedures are followed at all times in all areas they oversee, and that resources are provided to enable compliance;"
            },
            "type": "ListItem",
            "sequence_num": 77
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Assuring themselves that all staff working with medicines in the specified clinical area has the appropriate and up-to-date qualifications and competencies required;"
            },
            "type": "ListItem",
            "sequence_num": 78
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reporting any risks or incidents in relation to non-compliance with safe handling and security of medicines."
            },
            "type": "ListItem",
            "sequence_num": 79
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.12,
                "text": "Site Pharmacy Operations Manager"
            },
            "type": "ListItem",
            "sequence_num": 80
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that medicine control systems and procedures are followed at all times within site pharmacy department;"
            },
            "type": "ListItem",
            "sequence_num": 81
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that the security of all medicines, anywhere within the site pharmacy department is maintained at all times;"
            },
            "type": "ListItem",
            "sequence_num": 82
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring all staff working with medicines in pharmacy has the appropriate and up-to-date qualifications and competencies required;"
            },
            "type": "ListItem",
            "sequence_num": 83
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reporting any risks or incidents in relation to non-compliance with safe handling and security of medicines;"
            },
            "type": "ListItem",
            "sequence_num": 84
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All duties listed carried out below they personally perform."
            },
            "type": "ListItem",
            "sequence_num": 85
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.13,
                "text": "Senior registered professional in charge of a clinical area - Ward/ department manager (Ward sister/Charge nurse) or other professional equivalent in absence of Nurses and midwives."
            },
            "type": "ListItem",
            "sequence_num": 86
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that medicine control systems and procedures are followed at all times;"
            },
            "type": "ListItem",
            "sequence_num": 87
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that the security of all medicines, anywhere on the ward, unit or department is maintained at all times;"
            },
            "type": "ListItem",
            "sequence_num": 88
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring all staff working with medicines in the specified clinical area has the appropriate and up-to-date qualifications and competencies required;"
            },
            "type": "ListItem",
            "sequence_num": 89
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reporting any risks or incidents in relation to non-compliance with safe handling and security of medicines."
            },
            "type": "ListItem",
            "sequence_num": 90
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.14,
                "text": "All staff in roles involving handling of medicines at any point in course of their practice (this included but is not exhaustive to Medical, Nursing, Midwifery, Pharmacy, Allied Health-Professionals and all non-registered staff in professional- supporting roles handling medicines)"
            },
            "type": "ListItem",
            "sequence_num": 91
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring they are aware of and follow safe handling processes and procedures;"
            },
            "type": "ListItem",
            "sequence_num": 92
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure they only undertake tasks in which they are both permitted and competent;"
            },
            "type": "ListItem",
            "sequence_num": 93
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Undertake training where requested to do so and maintain competency;"
            },
            "type": "ListItem",
            "sequence_num": 94
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reporting any risks or incidents in relation to non-compliance with safe handling of medicines."
            },
            "type": "ListItem",
            "sequence_num": 95
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.15,
                "text": "Trainee Pharmacists"
            },
            "type": "ListItem",
            "sequence_num": 96
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.15.1 Trainee Pharmacists must be given every opportunity to become proficient in medicines related activities under appropriate supervision. They may only undertake tasks independently of registered pharmacy professionals once assessed as competent in accordance with pharmacy departmental procedures at all times, as per the responsible pharmacist regulations. Individual pharmacists are responsible when signing off any work which has been carried out by trainee pharmacists."
            },
            "type": "ListItem",
            "sequence_num": 97
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.15.2 Trainee pharmacists are not permitted to carry out a final clinical review/verification of a drug chart. This means they cannot authorise the supply of any medicine or discharge prescription without prior approval from a registered pharmacist."
            },
            "type": "ListItem",
            "sequence_num": 98
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.15.3 Trainee pharmacists are not permitted to final-check medicines prior to their release from the pharmacy, regardless of whether a pharmacist has clinically reviewed the order or not."
            },
            "type": "ListItem",
            "sequence_num": 99
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.15.4 Trainee pharmacists may report medication incidents, though a registered pharmacist must be notified in the first instance so that any clinical actions may be considered."
            },
            "type": "ListItem",
            "sequence_num": 100
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.16,
                "text": "Student Nurses, Midwives and Allied Health Professionals"
            },
            "type": "ListItem",
            "sequence_num": 101
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.16.1 Student practitioners must be given every opportunity to become proficient in medicines related activities under appropriate supervision. The supervising registrant has responsibility for medicine procedures at all times."
            },
            "type": "ListItem",
            "sequence_num": 102
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.16.2 Exclusions apply including in the case of controlled drugs. Refer to MSEPO-20237 Controlled Drugs Policy."
            },
            "type": "ListItem",
            "sequence_num": 103
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Controlled stationery and prescription charts or forms"
            },
            "type": "ListItem",
            "sequence_num": 104
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Controlled stationery security and handling is the responsibility of the ward/unit/department in which the stationery is stored. Therefore, the appointed manager (e.g. nurse-in-charge) is held responsible and accountable. Retention requirements for stationary and documentation records and actions to be taken in event of loss or theft are detailed in the respective Trust policies."
            },
            "type": "ListItem",
            "sequence_num": 105
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.1.1 For FP10s refer to MSEPO-21005 FP10 Prescription Policy and Procedure."
            },
            "type": "ListItem",
            "sequence_num": 106
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.1.2 For MSE hospital-only outpatient prescriptions refer to MSEPO-21187 Order and supply of paper hospital-only outpatient prescriptions."
            },
            "type": "ListItem",
            "sequence_num": 107
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.1.3 For Controlled Drug stationery (including registers) please refer to MSEPO-20237 Controlled Drugs Policy."
            },
            "type": "ListItem",
            "sequence_num": 108
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.2,
                "text": "Prescription charts and forms"
            },
            "type": "ListItem",
            "sequence_num": 109
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.2.1 The introduction of new or amended designs of all types of prescription charts/ forms used at the Trust, on which instructions to administer and prescriptions are written, must be approved by the Medicines Assurance Group before ratifying for printing."
            },
            "type": "ListItem",
            "sequence_num": 110
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.2.2 Prescription cards/forms must never be photocopied and used for prescribing except in circumstances detailed within the business continuity plan for Wellsky ePMA."
            },
            "type": "ListItem",
            "sequence_num": 111
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Procurement, acquisition and recall of medicines by pharmacy"
            },
            "type": "ListItem",
            "sequence_num": 112
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "The medicine must be appropriate and legitimate for its intended use."
            },
            "type": "ListItem",
            "sequence_num": 113
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "Medicines may only be purchased on behalf of the Trust by an authorised registered pharmacist or pharmacy technician in accordance with laid down procedures."
            },
            "type": "ListItem",
            "sequence_num": 114
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.3,
                "text": "The following processes are carried out by the department of pharmacy in accordance with their departmental procedures:"
            },
            "type": "ListItem",
            "sequence_num": 115
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Identification of potential sources of supply;"
            },
            "type": "ListItem",
            "sequence_num": 116
        },
        {
            "data": {
                "is_heading": 0,
                "text": "specification of the medicine for its intended use;"
            },
            "type": "ListItem",
            "sequence_num": 117
        },
        {
            "data": {
                "is_heading": 0,
                "text": "consideration of other issues such as lead times and shelf life;"
            },
            "type": "ListItem",
            "sequence_num": 118
        },
        {
            "data": {
                "is_heading": 0,
                "text": "method of procurement."
            },
            "type": "ListItem",
            "sequence_num": 119
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.4,
                "text": "The following policies are followed alongside the processes above:"
            },
            "type": "ListItem",
            "sequence_num": 120
        },
        {
            "data": {
                "is_heading": 0,
                "text": "For medicines supplied on a \"named patient\" basis, imported medicines and medicines known to be used outside the indications listed on the marketing authorisation see MSBPO-18017 Unlicensed Medicines Policy;"
            },
            "type": "ListItem",
            "sequence_num": 121
        },
        {
            "data": {
                "is_heading": 0,
                "text": "For clinical trial materials see MSEPO-20204 Safe Handling Effective Use and Management of Investigational Medicinal Products."
            },
            "type": "ListItem",
            "sequence_num": 122
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.5,
                "text": "For how to deal with drug samples which may be offered by representatives of the Pharmaceutical industry, refer to MSEPO- 21087 Dealing with Pharmaceutical Company Representatives and Drug Samples Policy. The only exception to this process will be in the case of \u2018bounty bags' used in maternity."
            },
            "type": "ListItem",
            "sequence_num": 123
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.6,
                "text": "Recall of medicines"
            },
            "type": "ListItem",
            "sequence_num": 124
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.6.1 Anyone becoming aware of a potentially defective medicine must contact the site pharmacy department immediately. Outside of pharmacy opening hours the on-call pharmacist should be informed for advice."
            },
            "type": "ListItem",
            "sequence_num": 125
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.6.2 If appropriate, a local recall will be instituted by pharmacy department and the manufacturer, and MHRA notified (via Yellow card or to the Defective Medicines Report Centre), where required."
            },
            "type": "ListItem",
            "sequence_num": 126
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.6.3 All recalls of medicines must be handled by the pharmacy department, in accordance with pharmacy departmental procedures."
            },
            "type": "ListItem",
            "sequence_num": 127
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.6.4 Recalls are co-ordinated via the Pharmacy Quality Assurance service who informs the relevant site pharmacy departments by the local reporting process. The necessary action is taken based on the class of the recall and documented records are completed and retained for reference."
            },
            "type": "ListItem",
            "sequence_num": 128
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.7,
                "text": "Supply of medicines to external (non-Trust) organisations"
            },
            "type": "ListItem",
            "sequence_num": 129
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.7.1 Supply of medicines to external organisations such as private hospitals, clinics etc., must only ever be carried out by the Trust pharmacy department. This is always in accordance with the documented and approved service level agreement with that organisation."
            },
            "type": "ListItem",
            "sequence_num": 130
        },
        {
            "data": {
                "is_heading": 0,
                "text": "6.7.2 External organisations must never provide Trust clinical areas with medicines. All supplies of medicines to our hospital services must be procured and supplied by the MSE Trust pharmacy department."
            },
            "type": "ListItem",
            "sequence_num": 131
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Manufacturing and manipulation of medicines"
            },
            "type": "ListItem",
            "sequence_num": 132
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "Medicines may be produced or modified by the hospital or a third party prior to administration to a patient, by appropriately trained and authorised staff under suitable conditions to maintain the quality, efficacy and safety of the medicines."
            },
            "type": "ListItem",
            "sequence_num": 133
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "This activity includes:"
            },
            "type": "ListItem",
            "sequence_num": 134
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Manufacturing of medicines from raw materials;"
            },
            "type": "ListItem",
            "sequence_num": 135
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Repackaging of medicines into small packs from bulk supply;"
            },
            "type": "ListItem",
            "sequence_num": 136
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Aseptic dispensing of parenteral nutrition solutions;"
            },
            "type": "ListItem",
            "sequence_num": 137
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reconstitution of injections;"
            },
            "type": "ListItem",
            "sequence_num": 138
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Addition of medicines to parenteral solutions;"
            },
            "type": "ListItem",
            "sequence_num": 139
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Preparation of oral liquids from solid dosage forms."
            },
            "type": "ListItem",
            "sequence_num": 140
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.3,
                "text": "In some cases, the point of manipulation may also be the point of issue (dispensing)."
            },
            "type": "ListItem",
            "sequence_num": 141
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.4,
                "text": "These activities may be carried out in the suitably-equipped hospital pharmacy or contracted out to commercial manufacturers. Full controls of all the processes are managed in order to sustain quality at the time of use. These are detailed within pharmacy departmental procedures."
            },
            "type": "ListItem",
            "sequence_num": 142
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Injectable medicines handling"
            },
            "type": "ListItem",
            "sequence_num": 143
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "All new injectable medicines are risk assessed to determine the safest presentation and location for storage and preparation in the clinical area before procurement and supply from pharmacy."
            },
            "type": "ListItem",
            "sequence_num": 144
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.2,
                "text": "Risk assessment will be based on the NPSA risk assessment scoring criteria for injectables. Factors within this scoring tool are:"
            },
            "type": "ListItem",
            "sequence_num": 145
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Therapeutic risk (i.e. potential toxicity to the patient resulting from maladministration);"
            },
            "type": "ListItem",
            "sequence_num": 146
        },
        {
            "data": {
                "is_heading": 0,
                "text": "the use of a concentrate to prepare the product;"
            },
            "type": "ListItem",
            "sequence_num": 147
        },
        {
            "data": {
                "is_heading": 0,
                "text": "the need for a complex calculation to obtain the dose or rate of administration;"
            },
            "type": "ListItem",
            "sequence_num": 148
        },
        {
            "data": {
                "is_heading": 0,
                "text": "the complexity of the preparation;"
            },
            "type": "ListItem",
            "sequence_num": 149
        },
        {
            "data": {
                "is_heading": 0,
                "text": "the use of a reconstituted vial or ampoule;"
            },
            "type": "ListItem",
            "sequence_num": 150
        },
        {
            "data": {
                "is_heading": 0,
                "text": "the use of part of multiple ampoules or vials;"
            },
            "type": "ListItem",
            "sequence_num": 151
        },
        {
            "data": {
                "is_heading": 0,
                "text": "the use of a pump or syringe driver;"
            },
            "type": "ListItem",
            "sequence_num": 152
        },
        {
            "data": {
                "is_heading": 0,
                "text": "the use of a non-standard giving set (e.g. PVC free required etc.)."
            },
            "type": "ListItem",
            "sequence_num": 153
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.3,
                "text": "Ready-to-administer/ ready-to-use medicines in clinical areas are preferable products to those needing preparation for use. Concentrates are only supplied by pharmacy where safer alternatives are not available."
            },
            "type": "ListItem",
            "sequence_num": 154
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.4,
                "text": "Based upon risk assessments the preparation and/or supply of medicines may be restricted to specified areas and by accredited individuals."
            },
            "type": "ListItem",
            "sequence_num": 155
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.5,
                "text": "The following medicines are always defined as high risk and must not be manipulated outside of a pharmacy aseptic manufacturing unit:"
            },
            "type": "ListItem",
            "sequence_num": 156
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Parenteral Nutrition: seals may be broken on dual and triple chamber bags but additions must not be made on wards or departments;"
            },
            "type": "ListItem",
            "sequence_num": 157
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Cytotoxic medicines for oncology use: are always provided in a ready to use presentation."
            },
            "type": "ListItem",
            "sequence_num": 158
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.5.1  Intrathecal analgesic pump refills may be undertaken by a registered nurse signed off as competent by the responsible Consultant."
            },
            "type": "ListItem",
            "sequence_num": 159
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.6,
                "text": "For those areas where high risk medicines are stocked, the local induction must include staff awareness of the dangers of the high risk medicines and ensure training is provided and evidenced for competent use and administration. It is the responsibility of that clinical division/specialty to ensure that this is in place."
            },
            "type": "ListItem",
            "sequence_num": 160
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Receipt of medicines"
            },
            "type": "ListItem",
            "sequence_num": 161
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "All procured medicines received onto Trust property must only be delivered to and signed for by the department of pharmacy."
            },
            "type": "ListItem",
            "sequence_num": 162
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.2,
                "text": "Sealed parcels of medicines may be accepted by Trust staff authorised by the site pharmacy Head of Department. The member of staff shall check that the parcels received correspond to those on the consignment note. They shall sign the consignment note to confirm acceptance. Such parcels must be taken to the pharmacy department, unopened, as soon as possible. Whilst awaiting delivery the parcels must be kept under the personal supervision of the person who received them. On receipt of parcels of medicines requiring special storage conditions pharmacy should be notified immediately."
            },
            "type": "ListItem",
            "sequence_num": 163
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.3,
                "text": "Medicines not in sealed parcels can only be accepted by pharmacy staff."
            },
            "type": "ListItem",
            "sequence_num": 164
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.4,
                "text": "Patients are encouraged to bring their own medicines into hospital, and can be used once the medicines have been assessed by a pharmacist or pharmacy technician as being suitable for use. Refer to MSEPO-21128 Administration of medicines policy."
            },
            "type": "ListItem",
            "sequence_num": 165
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Security of medicines within pharmacy"
            },
            "type": "ListItem",
            "sequence_num": 166
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "Medicines within pharmacy must be stored safely and securely. All departments run by pharmacy adhere to the same principles of safe secure storage as detailed within MSEPO-20205 Safe and Secure Storage of Medicines in Clinical Areas."
            },
            "type": "ListItem",
            "sequence_num": 167
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "There must be a suitable, working intruder alarm system in operation in all site pharmacies and pharmaceutical stores. This must be linked to notify the appropriate Trust site security staff."
            },
            "type": "ListItem",
            "sequence_num": 168
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.3,
                "text": "When the dispensary or pharmacy stores are not manned areas must be locked and alarmed at all times. It is not acceptable for staff working alone e.g. the on call pharmacist, to leave the pharmacy without locking and alarming the department. Door keypad locks alone are insufficient in this situation because staff requiring supervision may still be able to gain access."
            },
            "type": "ListItem",
            "sequence_num": 169
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.4,
                "text": "Keys, alarm codes and door codes to pharmacy must only be issued to authorised staff members that have a genuine need to access the department. The Pharmacy Operations Manager or equivalent service lead will decide who is permitted. In their absence the decision is taken by the site pharmacy Head of Department."
            },
            "type": "ListItem",
            "sequence_num": 170
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.5,
                "text": "Department keys and swipe-access cards must be returned when a member of staff leaves the Trust and alarm codes must be changed in the event that any security risk is identified."
            },
            "type": "ListItem",
            "sequence_num": 171
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.6,
                "text": "Staff from outside pharmacy who require access to the department e.g. facilities or nursing staff waiting for medication, must be supervised by a member of pharmacy staff at all times."
            },
            "type": "ListItem",
            "sequence_num": 172
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.7,
                "text": "Medicines, pharmaceutical excipients or any controlled stationary must never be accessible or reachable by the general public or other members of Trust staff."
            },
            "type": "ListItem",
            "sequence_num": 173
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Storage of medicines within pharmacy"
            },
            "type": "ListItem",
            "sequence_num": 174
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "Supplies of medicines must be stored within a site pharmacy or designated pharmaceutical store overseen by the department of pharmacy."
            },
            "type": "ListItem",
            "sequence_num": 175
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 25.0,
                "text": "All medication must be stored at an appropriate temperature in pharmacy. Air conditioning must be maintained and serviced regularly. Medicines requiring room temperature storage must be not stored at temperatures above  degrees Celsius, unless specifically specified otherwise by the manufacturer."
            },
            "type": "ListItem",
            "sequence_num": 176
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.3,
                "text": "Medication requiring cold storage must be stored in a fridge which maintains a temperature of between 2 and 8 degrees Celsius. Fridge monitoring systems are utilised in pharmacy which alerts staff to temperature deviations, which includes both air and fridge temperatures."
            },
            "type": "ListItem",
            "sequence_num": 177
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.4,
                "text": "Occasionally there is a need to store medicinal products in a freezer. For such products, a super freezer which stores medicines at a temperature of at least -20 degrees Celsius should be used, or cooler as per individual medicine requirement (e.g. vaccines)."
            },
            "type": "ListItem",
            "sequence_num": 178
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.5,
                "text": "Controlled Drugs are always stored in the designated controlled drugs room, which must always be closed when no staff are present. Refer to MSEPO-20237 Controlled Drugs Policy."
            },
            "type": "ListItem",
            "sequence_num": 179
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Ordering medicines from pharmacy"
            },
            "type": "ListItem",
            "sequence_num": 180
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.1,
                "text": "Stock medicines"
            },
            "type": "ListItem",
            "sequence_num": 181
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.1.1 A list of medicines to be held as stock in each clinical area shall be agreed between the designated registered pharmacist and clinical area manager (e.g. ward senior sister). This list shall be subject to regular review, at least annually. A paper copy is provided to the clinical area or is available electronically via the intranet."
            },
            "type": "ListItem",
            "sequence_num": 182
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.1.2 Where a pharmacy \u2018topping-up' service is in operation, pharmacy staff will restock clinical areas on a regular basis. The clinical area manager remains responsible for identifying fluctuations in requirements and ordering appropriately. They are also responsible for requesting adjustments to the agreed stock list and stock level when needed."
            },
            "type": "ListItem",
            "sequence_num": 183
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.1.3 Where a \u2018topping-up' service is not in operation, computer-generated stock sheets or requisitions will be completed and signed by the clinical area manager and sent to the pharmacy."
            },
            "type": "ListItem",
            "sequence_num": 184
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.1.4 Monitoring of storage is undertaken in accordance with MSEPO-20205 Safe and Secure Storage of Medicines in Clinical Areas."
            },
            "type": "ListItem",
            "sequence_num": 185
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.2,
                "text": "Inpatient items for individual patients"
            },
            "type": "ListItem",
            "sequence_num": 186
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.2.1 Inpatient medicines should be ordered against a valid prescription order on the drug chart / ePMA by registered pharmacy staff. Medicines cannot usually be supplied in absence of a prescription, except in exceptional circumstances at discretion of a registered pharmacist. Exceptional circumstances include critical medicines on grounds of patient safety. This will be in accordance with pharmacy department protocols."
            },
            "type": "ListItem",
            "sequence_num": 187
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.2.2 Ordering requests must be made by nursing/midwifery staff using the site paper ordering form (or equivalent) or on Wellsky ePMA as a \u2018Drug order' note (where used)."
            },
            "type": "ListItem",
            "sequence_num": 188
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "12.2.3 Critical medicines and urgent STAT doses must be accompanied by a phone call/ bleep (depending on site) to the ward pharmacy team. Refer also to MSEPO-21128 Administration of medicines policy, appendix  If requested (e.g. weekends when a ward pharmacy service is reduced), paper drug charts may be submitted to the site pharmacy dispensary during opening hours for ordering."
            },
            "type": "ListItem",
            "sequence_num": 189
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.2.4 All ordered medicines are entered onto the site prescription tracking system for clinical areas to track when their orders are dispensed by the site pharmacy."
            },
            "type": "ListItem",
            "sequence_num": 190
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.2.5 In general, most wards will have their medicines supplied labelled with patient directions on how to take. Medicines are ordered by pharmacy staff using designated ordering sheets (or electronically via Wellsky ePMA)."
            },
            "type": "ListItem",
            "sequence_num": 191
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.2.6 Where it is not possible to label a non-stock medicine with directions, the medicine will be labelled with the patient's name only. Medicines without labelled directions must NEVER be issued to patients on discharge because this is illegal practice. These medicines must be stored in the appropriate ward drug trolley/cupboard and not the patient's bedside locker."
            },
            "type": "ListItem",
            "sequence_num": 192
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.3,
                "text": "For Controlled drugs refer to MSEPO-20237 Controlled Drugs Policy."
            },
            "type": "ListItem",
            "sequence_num": 193
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.4,
                "text": "For pre-labelled packs refer to MSEPO-21144 Discharge TTA medication policy for supply requirements."
            },
            "type": "ListItem",
            "sequence_num": 194
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.5,
                "text": "Outpatient items"
            },
            "type": "ListItem",
            "sequence_num": 195
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.5.1 Outpatient items are dispensed in the pharmacy dispensary and are usually collected by the patient or their representative."
            },
            "type": "ListItem",
            "sequence_num": 196
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.5.2 Medicines may not be given to anybody other than the patient without their permission and if there is any doubt as to whether a medicine should be given out, advice should be sought from the team leader in charge of the dispensary. Patients or representatives are required to provide suitable identification for Controlled Drugs (see MSEPO-20237 Controlled Drugs Policy)."
            },
            "type": "ListItem",
            "sequence_num": 197
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.5.3 Outpatient dispensed medicines may be sent to patients in specific circumstances as detailed within pharmacy department procedures. Medicines will be sent using a Trust approved courier service. Documented records are maintained of all medicines sent to patients by pharmacy."
            },
            "type": "ListItem",
            "sequence_num": 198
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.5.4 In exceptional circumstances an outpatient dispensed medicine may need to be sent to a patient urgently on grounds of patient safety. A secure delivery service will be organised by pharmacy (i.e. specific taxi) for this purpose. This will be in accordance with Courier and Taxi Policy, or equivalent."
            },
            "type": "ListItem",
            "sequence_num": 199
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.5.5 Sending medicines to patients should only be considered if there are genuine reasons why it would be difficult for a patient to collect themselves."
            },
            "type": "ListItem",
            "sequence_num": 200
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.5.6 Medicines must not be sent to patients by post, except where this is risk assessed and authorised in writing by both the clinical specialty and site Pharmacy Head of Department."
            },
            "type": "ListItem",
            "sequence_num": 201
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Dispensing or supply to point of use"
            },
            "type": "ListItem",
            "sequence_num": 202
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.1,
                "text": "Prior to dispensing of any non-stock medicines (i.e. supplied to named/identified patient) prescriptions must be always clinically screened/ verified by a registered pharmacist. This is undertaken in accordance with pharmacy departmental procedures in line with professional clinical judgement."
            },
            "type": "ListItem",
            "sequence_num": 203
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.2,
                "text": "Dispensing is carried out in accordance with pharmacy departmental procedures that define the requirements on the labelling and assembly of the medicines container."
            },
            "type": "ListItem",
            "sequence_num": 204
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.3,
                "text": "A final technical accuracy check is undertaken for all items dispensed as an inpatient, TTA or outpatient item before being packaged as ready to supply."
            },
            "type": "ListItem",
            "sequence_num": 205
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.4,
                "text": "Items supplied against a defined clinical area stock list are supplied separately in accordance with pharmacy departmental procedures. These are supplied without dispensing labels as a stock issue rather than \u2018dispensed'."
            },
            "type": "ListItem",
            "sequence_num": 206
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Transportation of medicines"
            },
            "type": "ListItem",
            "sequence_num": 207
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.1,
                "text": "Delivery packages within the Trust"
            },
            "type": "ListItem",
            "sequence_num": 208
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.1.1 All delivery bags/containers are closed with a tamper-evident seal before leaving pharmacy. This may be a security tag or tamper-evident tape."
            },
            "type": "ListItem",
            "sequence_num": 209
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.1.2 Fridge-stored medication is supplied by pharmacy in bags marked clearly \u2018Fridge items' or \u2018Refrigerated items enclosed' in large print or using a bright coloured sticker. Individual medication containers are additionally labelled \u2018store in fridge'. Items must be placed in the clinical area fridge immediately on receipt."
            },
            "type": "ListItem",
            "sequence_num": 210
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.1.3 Controlled Drugs are supplied from pharmacy in tamper-evident containers and must be signed for on receipt. Refer to MSEPO-20237 Controlled Drugs Policy for requirements for collection and transportation."
            },
            "type": "ListItem",
            "sequence_num": 211
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.1.4 Cytotoxic medicines are transported in bags designated and labelled for such purpose. Intrathecal chemotherapy must only be delivered in accordance with MSEPO-21088 Management of IntraTHECAL Chemotherapy Policy."
            },
            "type": "ListItem",
            "sequence_num": 212
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.1.5 Ambient (room temperature) stored medication is supplied in standard pharmacy bags."
            },
            "type": "ListItem",
            "sequence_num": 213
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.1.6 Medicines, other than controlled drugs and cytotoxics, that are suitable for delivery by vacuum tube system (where available) must be securely packed in a suitable transit container and transmitted to a secure location only accessible with the permission of the nurse in charge."
            },
            "type": "ListItem",
            "sequence_num": 214
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.2,
                "text": "Collection from pharmacy"
            },
            "type": "ListItem",
            "sequence_num": 215
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.2.1 Medicines which are critically urgent are requested to be collected by a member of authorised staff from the clinical area from pharmacy. Additional restrictions apply for Controlled Drugs (see MSEPO-20237 Controlled Drugs Policy)."
            },
            "type": "ListItem",
            "sequence_num": 216
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.2.2 Medicines may also be requested to be collected at weekends, bank holidays and out of hours, at the request of pharmacy staff."
            },
            "type": "ListItem",
            "sequence_num": 217
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.2.3 Authorised persons must have valid Trust photo identification on presentation at the site pharmacy. These are persons permitted to collect medicines on that occasion by the nurse/midwife-in-charge, and can include healthcare assistants and ward clerks. Trainee/student healthcare professionals may collect medicines provided the pharmacy can be assured that they are genuinely working on the ward (as they may not hold a Trust photo ID badge, only the educational institution badge). Checks are made via telephone call between pharmacy and the clinical area, when required."
            },
            "type": "ListItem",
            "sequence_num": 218
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.3,
                "text": "Delivery from pharmacy to clinical areas"
            },
            "type": "ListItem",
            "sequence_num": 219
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.3.1 Stock list medicines and non-urgent requests are delivered to the clinical area by default by designated person/s from the site pharmacy department. This service operates Mondays-Fridays. Outside these hours, clinical areas may be requested to collect their medicines from pharmacy."
            },
            "type": "ListItem",
            "sequence_num": 220
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.3.2 Staffs engaged in transportation of medicines on behalf of pharmacy are readily identifiable, authorised by the site pharmacy department and appropriately trained."
            },
            "type": "ListItem",
            "sequence_num": 221
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.3.3 Equipment used in the transport medicines is designed to ensure that the integrity and quality of medicines delivered is not compromised. Deliveries are always secured and never left unattended."
            },
            "type": "ListItem",
            "sequence_num": 222
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.3.4 Ambient stored stock medicines must always be delivered into a lockable and locked medication room."
            },
            "type": "ListItem",
            "sequence_num": 223
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.3.5 Fridge-stored and controlled drugs must always be handed to a registered nurse or midwife. Staff in the clinical area must sign for receipt in accordance with MSEPO- 20237 Controlled Drugs Policy and any other receipt documentation requested by the pharmacy delivery person."
            },
            "type": "ListItem",
            "sequence_num": 224
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.4,
                "text": "Transportation requirements outside the hospital site (including to a patient's place of residence)"
            },
            "type": "ListItem",
            "sequence_num": 225
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.4.1 Tamper-evident and secured containers should be used when the transportation is under personal control throughout. Secured containers in secured vehicles should be used when the medicines are not under personal control throughout the transportation. The vehicle used to transport medicines must be kept locked when unoccupied."
            },
            "type": "ListItem",
            "sequence_num": 226
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.4.2 Medication must be transported in accordance with requirements for secure storage and Courier and Taxi Policy or equivalent."
            },
            "type": "ListItem",
            "sequence_num": 227
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.5,
                "text": "Transportation of medication between Trust sites and external organisations"
            },
            "type": "ListItem",
            "sequence_num": 228
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.5.1 Medication must only be transferred between Trust sites and external organisations under authority of the department of pharmacy. The only exception to this is patient- specific labelled medicines that travel with a patient as part of a ward-ward transfer arrangement."
            },
            "type": "ListItem",
            "sequence_num": 229
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.5.2 Medication sent from pharmacy will always be provided in tamper-evident and secure containers or sealed tamper evident roll cages."
            },
            "type": "ListItem",
            "sequence_num": 230
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.5.3 A full documented audit trail exists between the supplying pharmacy department and the receiving department (which usually will be another site pharmacy department). This includes documented numbers of sealed containers or roll-cages to be transported. This is in accordance with pharmacy procedures and accompanies each delivery."
            },
            "type": "ListItem",
            "sequence_num": 231
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.5.4 Medicines which require refrigeration (e.g. vaccines) must be accompanied by a consignment note on which is recorded the time of leaving the pharmacy and the time of placing in the refrigerator at the destination."
            },
            "type": "ListItem",
            "sequence_num": 232
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.5.5 Transfer of medicines outside the healthcare organisation should always be authorised and receipt acknowledged by the receiving body. A signature shall be obtained each time the consignment changes hands."
            },
            "type": "ListItem",
            "sequence_num": 233
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "COSHH requirements"
            },
            "type": "ListItem",
            "sequence_num": 234
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.1,
                "text": "Pharmaceutical products and / or excipients may have the potential to cause harm if not handled appropriately."
            },
            "type": "ListItem",
            "sequence_num": 235
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.2,
                "text": "Relevant COSHH assessments are undertaken in accordance with the MSEPO- 20218 Control of Substances Hazardous to Health Policy (COSHH). Clinical areas and site pharmacy / pharmaceutical departments must ensure where particular products require extra precautions, all required equipment is available at all times."
            },
            "type": "ListItem",
            "sequence_num": 236
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.3,
                "text": "Hazardous products must be stored appropriately and segregated where necessary e.g. cytotoxic drugs, flammable products."
            },
            "type": "ListItem",
            "sequence_num": 237
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Strong potassium solution (potassium chloride concentrate"
            },
            "type": "ListItem",
            "sequence_num": 238
        },
        {
            "data": {
                "is_heading": 1,
                "text": "solution)"
            },
            "type": "ListItem",
            "sequence_num": 239
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.1,
                "text": "Strong potassium solution (potassium chloride concentrate solution) can be fatal if given inappropriately. Potassium chloride concentrate ampoules can look very similar to sodium chloride 0.9%, water for injections and other injectable medicines. Historical incidents globally (including the UK) identified where potassium chloride has been accidentally administered to patients with fatal results."
            },
            "type": "ListItem",
            "sequence_num": 240
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.2,
                "text": "Mis-selection of strong potassium solution (potassium chloride concentrate solutions) is part of an NHS Never Event, when a patient is intravenously given a strong potassium solution rather than the intended medication. This is implicated in severe patient harm and fatal incidents."
            },
            "type": "ListItem",
            "sequence_num": 241
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.3,
                "text": "A national patient safety alert for strong potassium solutions exists (NPSA, 2002) in order to reduce the risk of accidental overdose, whilst ensuring that potassium preparations are still readily available to treat seriously ill patients promptly."
            },
            "type": "ListItem",
            "sequence_num": 242
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.4,
                "text": "The Trust has systems in place to reduce and eliminate the risk of inadvertent administration of strong potassium solution, in alignment with the requirements of the patient safety alert (NPSA, 2002). These are set out below."
            },
            "type": "ListItem",
            "sequence_num": 243
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.5,
                "text": "In context of this policy, potassium chloride concentrate solutions are those >10% presented in ampoules or vials. The only potassium chloride concentrate solutions available this Trust in ampoules are:"
            },
            "type": "ListItem",
            "sequence_num": 244
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Potassium Chloride 15%w/v (20mmol in10ml);"
            },
            "type": "ListItem",
            "sequence_num": 245
        },
        {
            "data": {
                "is_heading": 0,
                "text": "AddiPhos\u00ae (potassium 30mmol, phosphate 40 mmol, sodium 30 mmol in 20ml)."
            },
            "type": "ListItem",
            "sequence_num": 246
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.6,
                "text": "Preparation of dilute solutions containing potassium"
            },
            "type": "ListItem",
            "sequence_num": 247
        },
        {
            "data": {
                "is_heading": 0,
                "text": "16.6.1 Potassium solutions for intravenous administration will be prescribed in those concentrations that are commercially available as \u2018standard'."
            },
            "type": "ListItem",
            "sequence_num": 248
        },
        {
            "data": {
                "is_heading": 0,
                "text": "16.6.2 Pharmacy should be consulted for up to date information on preparations available. Clinical areas must be aware that they may not routinely stock all preparations available to them."
            },
            "type": "ListItem",
            "sequence_num": 249
        },
        {
            "data": {
                "is_heading": 0,
                "text": "16.6.3 Only in exceptional circumstances, where there is a clear clinical reason for deviation from these standard preparations should alternatives be considered."
            },
            "type": "ListItem",
            "sequence_num": 250
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.7,
                "text": "Potassium chloride concentrate solution ampoules/vials must only be used when a suitable pre-prepared ready diluted preparation does not exist (i.e. not available from pharmacy)."
            },
            "type": "ListItem",
            "sequence_num": 251
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 16.8,
                "text": "Prescribing"
            },
            "type": "ListItem",
            "sequence_num": 252
        },
        {
            "data": {
                "is_heading": 0,
                "text": "16.8.1 The prescribing of bespoke fluids using potassium chloride concentrate solutions is the responsibility of a registrar, associate specialist or consultant only."
            },
            "type": "ListItem",
            "sequence_num": 253
        },
        {
            "data": {
                "is_heading": 0,
                "text": "16.8.2 Junior doctors (FY1 and 2) are not permitted to prescribe non-standard potassium solutions."
            },
            "type": "ListItem",
            "sequence_num": 254
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 16.9,
                "text": "Storage and handling"
            },
            "type": "ListItem",
            "sequence_num": 255
        },
        {
            "data": {
                "is_heading": 0,
                "text": "16.9.1 All potassium chloride concentrate solution ampoules (Potassium Chloride 15%w/v and AddiPhos\u00ae) must be treated and handled as a Schedule 2 Controlled drug."
            },
            "type": "ListItem",
            "sequence_num": 256
        },
        {
            "data": {
                "is_heading": 0,
                "text": "16.9.2 This means ordering and storing as a CD, and full register transactions. See MSEPO-20237 Controlled Drug Policy and Procedures."
            },
            "type": "ListItem",
            "sequence_num": 257
        },
        {
            "data": {
                "is_heading": 0,
                "text": "16.9.3 Potassium chloride concentrate solution ampoules must never be transferred between clinical areas. Areas must obtain them through pharmacy during the working day and the on-call pharmacist out of hours."
            },
            "type": "ListItem",
            "sequence_num": 258
        },
        {
            "data": {
                "is_heading": 0,
                "text": "16.9.4 Only locations deemed to be \u201ccritical care areas\u201d may routinely stock potassium chloride concentrate solution ampoules (See table 1 and 2). This must be agreed with the Principal/ Clinical Lead Pharmacist, Matron and authorised by the Controlled Drugs Accountable Officer (CDAO)."
            },
            "type": "ListItem",
            "sequence_num": 259
        },
        {
            "type": "table",
            "sequence_num": 260,
            "data": {
                "num_rows": 12,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Table 1: Clinical Areas authorised to stock Potassium Chloride 15%w/v (20mmol in10ml)"
                    },
                    {
                        "text": "Broomfield site"
                    },
                    {
                        "text": "Southend site"
                    },
                    {
                        "text": "Basildon site"
                    },
                    {
                        "text": "Intensive Care Unit (ICU) E226"
                    },
                    {
                        "text": "Critical Care Unit"
                    },
                    {
                        "text": "Critical Care Unit"
                    },
                    {
                        "text": "Medical High Dependency Unit (MHDU) A211"
                    },
                    {
                        "text": "High Dependency Unit (HDU)"
                    },
                    {
                        "text": "Frederick Banting (ITU)"
                    },
                    {
                        "text": "Burns ITU E220"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "AandE (Resus)"
                    },
                    {
                        "text": "AandE (Resus)"
                    },
                    {
                        "text": "Accident and Emergency"
                    },
                    {
                        "text": "Neonatal Unit A406"
                    },
                    {
                        "text": "Neonatal Unit"
                    },
                    {
                        "text": "Neonatal Intensive Care"
                    },
                    {
                        "text": "Phoenix Ward E122"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Theatres"
                    },
                    {
                        "text": "Theatres (Main and CTC)"
                    },
                    {
                        "text": "Theatre Recovery"
                    },
                    {
                        "text": "Post Op"
                    },
                    {
                        "text": "Main Theatre Recovery"
                    },
                    {
                        "text": "Maternity Theatre Recovery"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Basildon Day Unit (BDU)"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 261,
            "data": {
                "num_rows": 5,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Table 2: Clinical Areas authorised to stock AddiPhos\u00ae"
                    },
                    {
                        "text": "Broomfield"
                    },
                    {
                        "text": "Southend"
                    },
                    {
                        "text": "Basildon"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Critical Care Unit"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Colne Ward (in CTC)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Frederick Banting (ITU)"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 16.1,
                "text": "Safe administration principles with IV potassium"
            },
            "type": "ListItem",
            "sequence_num": 262
        },
        {
            "data": {
                "is_heading": 0,
                "text": "16.10.1 The dose and rate must be adjusted according to the patient's condition."
            },
            "type": "ListItem",
            "sequence_num": 263
        },
        {
            "data": {
                "is_heading": 0,
                "text": "16.10.2 All infusions containing Potassium must be delivered by a controlled infusion device e.g. volumetric infusion pump."
            },
            "type": "ListItem",
            "sequence_num": 264
        },
        {
            "data": {
                "is_heading": 0,
                "text": "16.10.3 The preparation and administration of all potassium-containing solutions must have a second check by an authorised practitioner before administration."
            },
            "type": "ListItem",
            "sequence_num": 265
        },
        {
            "data": {
                "is_heading": 0,
                "text": "16.10.4 Patients must be monitored for pain and phlebitis at the infusion site for peripheral administration."
            },
            "type": "ListItem",
            "sequence_num": 266
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 16.11,
                "text": "Administration of Intravenous (IV) Potassium solutions in adults"
            },
            "type": "ListItem",
            "sequence_num": 267
        },
        {
            "data": {
                "is_heading": 1,
                "text": "16.11.1 Administration via a peripheral venous access:"
            },
            "type": "ListItem",
            "sequence_num": 268
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Use a ready-made bag with a maximum concentration of 40mmol potassium per litre, using an infusion pump. Maximum infusion rate 20mmol per hour."
            },
            "type": "ListItem",
            "sequence_num": 269
        },
        {
            "data": {
                "is_heading": 0,
                "text": "In exceptional circumstances a higher concentration may be administered but this must be confirmed with both the prescriber and a senior pharmacist (8a or above) before administration following a suitable patient-specific risk assessment documented in the notes."
            },
            "type": "ListItem",
            "sequence_num": 270
        },
        {
            "data": {
                "is_heading": 1,
                "text": "16.11.2 Administration via a central venous access:"
            },
            "type": "ListItem",
            "sequence_num": 271
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Concentrations greater than 40mmol per litre must always be given via a central venous access device, using a suitable infusion pump; ready-made solutions should be used wherever possible."
            },
            "type": "ListItem",
            "sequence_num": 272
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Rate of administration:"
            },
            "type": "ListItem",
            "sequence_num": 273
        },
        {
            "type": "table",
            "sequence_num": 274,
            "data": {
                "num_rows": 4,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Table 3: IV Potassium ECG monitoring requirement"
                    },
                    {
                        "text": "Rate of administration"
                    },
                    {
                        "text": "ECG monitoring"
                    },
                    {
                        "text": "\u226420mmol/hour"
                    },
                    {
                        "text": "Not required"
                    },
                    {
                        "text": "20 to 40mmol/hour"
                    },
                    {
                        "text": "Required"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 16.12,
                "text": "Administration of Potassium in paediatric patients"
            },
            "type": "ListItem",
            "sequence_num": 275
        },
        {
            "data": {
                "is_heading": 1,
                "text": "16.12.1 Administration via a peripheral venous access:"
            },
            "type": "ListItem",
            "sequence_num": 276
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The recommended maximum rate is 0.2mmol potassium /kg/hour (up to maximum of 20mmol/hour) using an infusion pump. The concentration of potassium should not exceed 40mmol/litre (20mmol/500ml)."
            },
            "type": "ListItem",
            "sequence_num": 277
        },
        {
            "data": {
                "is_heading": 1,
                "text": "16.12.2 Paediatric intensive care units and restricted areas only, under specialist supervision - see local specialty guidance. Via a central venous access device:"
            },
            "type": "ListItem",
            "sequence_num": 278
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Continuous ECG monitoring is required for rates exceeding 0.2mmol/kg/hour. Usual maximum rate is 0.5mmol/kg/hour (but no more than 20mmol/hour)."
            },
            "type": "ListItem",
            "sequence_num": 279
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Cytotoxic medicines"
            },
            "type": "ListItem",
            "sequence_num": 280
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.1,
                "text": "Cytotoxic drugs must be handled in accordance with the Policy for Safe Prescribing, Handling and Administration of Systemic Anticancer Therapy."
            },
            "type": "ListItem",
            "sequence_num": 281
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.2,
                "text": "Doses of injectable cytotoxic drugs must be prepared (or obtained ready-made by pharmacy) in the pharmacy department in facilities designed for the purpose."
            },
            "type": "ListItem",
            "sequence_num": 282
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.3,
                "text": "Doses of injectable cytotoxic drugs may only be administered by appropriately trained medical or nursing staff who have been specifically designated to administer cytotoxic drugs by the lead Nurse and Consultant in that speciality."
            },
            "type": "ListItem",
            "sequence_num": 283
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.4,
                "text": "Only appropriately qualified and competent Consultant Medical Oncologists, Clinical Oncologists, Haematologists and Paediatric Oncologists may initiate a new course and prescribe the first cycle of systemic anti-cancer therapy for the treatment of cancer patients."
            },
            "type": "ListItem",
            "sequence_num": 284
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.5,
                "text": "IntraTHECAL chemotherapy must only be administered in line with MSEPO-21088 Management of IntraTHECAL Chemotherapy Policy."
            },
            "type": "ListItem",
            "sequence_num": 285
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.6,
                "text": "Cytotoxic Drugs for indications other than cancer should be initiated by a Consultant with appropriate follow up and monitoring by the specialist"
            },
            "type": "ListItem",
            "sequence_num": 286
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 17.7,
                "text": "Oral cytotoxic drug administration"
            },
            "type": "ListItem",
            "sequence_num": 287
        },
        {
            "data": {
                "is_heading": 0,
                "text": "17.7.1 Tablets and capsules should not be handled."
            },
            "type": "ListItem",
            "sequence_num": 288
        },
        {
            "data": {
                "is_heading": 0,
                "text": "17.7.2 Since most tablets are film coated they should not be broken or crushed before administration. The tablet or capsule should be swallowed whole. Any exceptions to this will be clearly documented by the pharmacist on all prescription / administration paperwork."
            },
            "type": "ListItem",
            "sequence_num": 289
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Managing waste and unwanted medicines within clinical areas"
            },
            "type": "ListItem",
            "sequence_num": 290
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.1,
                "text": "This section must be used in conjunction with MSEPO-21112 Waste Management Policy and Procedure."
            },
            "type": "ListItem",
            "sequence_num": 291
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 18.2,
                "text": "Cytotoxic medicines, cytostatic medicines and vaccines"
            },
            "type": "ListItem",
            "sequence_num": 292
        },
        {
            "data": {
                "is_heading": 0,
                "text": "18.2.1 Cytostatic medicines are distinct from cytotoxic medicines but they need to be disposed of in the same way. Cytostatic medicines are those medicines which in some way may have adverse effects which are not sufficiently serious to be classified as cytotoxic, but can have other unwanted effects e.g. drugs which interfere with reproduction or can cause blood dyscrasias. Since there are relatively few of these drugs which are used routinely by the injectable route, a cytotoxic waste bin will be provided by pharmacy if such a product is supplied to a clinical area."
            },
            "type": "ListItem",
            "sequence_num": 293
        },
        {
            "data": {
                "is_heading": 0,
                "text": "18.2.2 All containers and sharps which contain any residue of any vaccine, Botulin toxin, BCG or any cytotoxic or cytostatic must be placed in a cytotoxic waste bin, which must then be sealed before sending for disposal. Full bins must not be allowed to accumulate on the ward, department or clinic. Part-used bins should be sealed and removed from the ward if they are not likely to be filled within a few days."
            },
            "type": "ListItem",
            "sequence_num": 294
        },
        {
            "data": {
                "is_heading": 0,
                "text": "18.2.3 Unused doses of chemotherapy should be returned unopened to pharmacy. Part used bags or syringes disposal is the responsibility of the clinical area in accordance with MSEPO-21112 Waste management policy and procedure."
            },
            "type": "ListItem",
            "sequence_num": 295
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 18.3,
                "text": "Controlled Drugs: Refer to MSEPO-20237 Controlled Drugs Policy."
            },
            "type": "ListItem",
            "sequence_num": 296
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 18.4,
                "text": "Radioactive pharmaceutical waste: Returned to the Nuclear Medicine department for disposal in accordance with Nuclear Medicine departmental procedures."
            },
            "type": "ListItem",
            "sequence_num": 297
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 18.5,
                "text": "Waste disposal for all other medicines types"
            },
            "type": "ListItem",
            "sequence_num": 298
        },
        {
            "data": {
                "is_heading": 0,
                "text": "18.5.1 A dose of medicine prepared for administration and subsequently not used must be disposed of safely by placing in the designated waste container and disposing as per MSEPO-21112 Waste management policy and procedure. The dose must never be returned to its original container and kept."
            },
            "type": "ListItem",
            "sequence_num": 299
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 21112.0,
                "text": "18.5.2 Unwanted Patients own medicines, out-of-date medicines and opened liquids (except CDs) may also be disposed of at ward level in accordance with MSEPO- Waste management policy and procedure. Patient consent should be obtained for disposal."
            },
            "type": "ListItem",
            "sequence_num": 300
        },
        {
            "data": {
                "is_heading": 0,
                "text": "18.5.3 All other unwanted medicines waste (i.e. packets of tablets, capsules, and injections etc. that are:"
            },
            "type": "ListItem",
            "sequence_num": 301
        },
        {
            "data": {
                "is_heading": 0,
                "text": "In their original containers and;"
            },
            "type": "ListItem",
            "sequence_num": 302
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Within expiry date and;"
            },
            "type": "ListItem",
            "sequence_num": 303
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Issued by the MSE hospital pharmacy;"
            },
            "type": "ListItem",
            "sequence_num": 304
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Should be returned to the pharmacy as soon as they are no longer required."
            },
            "type": "ListItem",
            "sequence_num": 305
        },
        {
            "data": {
                "is_heading": 0,
                "text": "18.5.4 Returns to pharmacy must be placed in the designated pharmacy returns receptacle/cupboard (depending on site). Never place any other consumables in pharmacy returns."
            },
            "type": "ListItem",
            "sequence_num": 306
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 18.6,
                "text": "Handling of medicines for deceased patients"
            },
            "type": "ListItem",
            "sequence_num": 307
        },
        {
            "data": {
                "is_heading": 0,
                "text": "18.6.1 No medication must be sent to the mortuary with the patient. Checks for medicated patches should be made by the registered nurse (or equivalent) caring for the patient. If present they should be removed and disposed of in accordance with MSEPO-21112 Waste management policy and procedure or MSEPO-20237 Controlled Drugs Policy as appropriate."
            },
            "type": "ListItem",
            "sequence_num": 308
        },
        {
            "data": {
                "is_heading": 0,
                "text": "18.6.2 All unused medicines belonging to the patient must be retained on the ward and disposed of/returned to pharmacy as above."
            },
            "type": "ListItem",
            "sequence_num": 309
        },
        {
            "data": {
                "is_heading": 0,
                "text": "18.6.3 Patient own controlled drugs must be retained on the ward until signed out of the controlled drug register by registered pharmacy staff. Refer to MSEPO-20237 Controlled Drugs Policy."
            },
            "type": "ListItem",
            "sequence_num": 310
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.7,
                "text": "Removal of sealed bins of waste medicines is disposed of in accordance with the current special waste regulations and MSEPO-21112 Waste management policy and procedure."
            },
            "type": "ListItem",
            "sequence_num": 311
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Community nursing and midwifery"
            },
            "type": "ListItem",
            "sequence_num": 312
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 19.1,
                "text": "Both Nurses and Midwives in the community should refer to the following policies that cover community practice:"
            },
            "type": "ListItem",
            "sequence_num": 313
        },
        {
            "data": {
                "is_heading": 0,
                "text": "MSEPO-20205 Policy for Safe and Secure Storage of Medicines;"
            },
            "type": "ListItem",
            "sequence_num": 314
        },
        {
            "data": {
                "is_heading": 0,
                "text": "MSEPO-21128 Administration of medicines policy."
            },
            "type": "ListItem",
            "sequence_num": 315
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 19.2,
                "text": "For the disposal of unwanted medication, for controlled drugs refer to MSEPO- 20237 Controlled Drug Policy. For all other medicines supplied these should be returned to the supplying pharmacy when no longer required."
            },
            "type": "ListItem",
            "sequence_num": 316
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 19.3,
                "text": "Medicines dispensed for home use by individual patients are the patient's own property, even when they are no longer required. They shall not be removed by the nurse or midwife but the patient or carer (if applicable) should be advised to return them to the supplying community pharmacy."
            },
            "type": "ListItem",
            "sequence_num": 317
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 19.4,
                "text": "A record of the intention to return to the pharmacy should be made in the patient's notes. If a patient or carer refuses to dispose of medicines this should be recorded in the patient's healthcare records. The relevant staff member's manager and GP (if relevant) should be informed."
            },
            "type": "ListItem",
            "sequence_num": 318
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 19.5,
                "text": "Transport of medicines"
            },
            "type": "ListItem",
            "sequence_num": 319
        },
        {
            "data": {
                "is_heading": 0,
                "text": "19.5.1  Except when carried on the person of authorised staff members, medicines must be kept out of sight in a locked car while the nurse/midwife is on their rounds. Controlled drugs must be in a locked container. Refer to Controlled Drug and storage of medicines policies."
            },
            "type": "ListItem",
            "sequence_num": 320
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 19.6,
                "text": "Community Midwife supply of medicines"
            },
            "type": "ListItem",
            "sequence_num": 321
        },
        {
            "data": {
                "is_heading": 0,
                "text": "19.6.1 Controlled drugs for home deliveries shall be obtained for each individual patient against a prescription from the GP ahead of time. The prescription should be dispensed at a local community pharmacy. Refer to MSEPO-20237 Controlled Drug Policy."
            },
            "type": "ListItem",
            "sequence_num": 322
        },
        {
            "data": {
                "is_heading": 0,
                "text": "19.6.2 Midwives may also obtain from the hospital pharmacy stocks of those medicines which have been authorised by the Division Medical Director, Director of Midwifery and Chief Pharmacist. Orders must be made using a pharmacy requisition book (or equivalent)."
            },
            "type": "ListItem",
            "sequence_num": 323
        },
        {
            "data": {
                "is_heading": 0,
                "text": "19.6.3 Any other medicines required must be prescribed for the use of individual patients."
            },
            "type": "ListItem",
            "sequence_num": 324
        },
        {
            "data": {
                "is_heading": 0,
                "text": "19.6.4 Records maintained by each midwife of medicines kept in their possession must always be available for audit by the Lead Midwife for community services, or designated deputy. The Lead Midwife is responsible for undertaking checks and investigating any discrepancies. If unresolved these are reported to the Chief Pharmacist and Director of Midwifery and site Head of Midwifery."
            },
            "type": "ListItem",
            "sequence_num": 325
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 20.0,
                "text": "Training requirements"
            },
            "type": "ListItem",
            "sequence_num": 326
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.1,
                "text": "Training is delivered in-house by the pharmacy department for all pharmacy staff involved in the procurement and supply of medicines. This is undertaken in accordance with pharmacy induction programmes and departmental procedures."
            },
            "type": "ListItem",
            "sequence_num": 327
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.2,
                "text": "No specific training requirements for other staff."
            },
            "type": "ListItem",
            "sequence_num": 328
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 21.0,
                "text": "Monitoring and audit"
            },
            "type": "ListItem",
            "sequence_num": 329
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 21.1,
                "text": "Outlined below is the Trust's process of monitoring compliance with, and the effectiveness of the document's main points."
            },
            "type": "ListItem",
            "sequence_num": 330
        },
        {
            "type": "table",
            "sequence_num": 331,
            "data": {
                "num_rows": 3,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Aspect of compliance or effectiveness being monitored"
                    },
                    {
                        "text": "Monitoring Method"
                    },
                    {
                        "text": "Individual department responsible for the monitoring"
                    },
                    {
                        "text": "Frequency of the monitoring activity"
                    },
                    {
                        "text": "Group / Committee / forum which will receive the findings/monitoring report"
                    },
                    {
                        "text": "Committee / individual responsible for ensuring the actions are completed"
                    },
                    {
                        "text": "Reviewing medication stock lists in clinical locations"
                    },
                    {
                        "text": "Stock List Review Programme"
                    },
                    {
                        "text": "Site Senior Technician- Pharmacy Distribution/ stores Services"
                    },
                    {
                        "text": "Quarterly (rolling)"
                    },
                    {
                        "text": "Pharmacy Management Team"
                    },
                    {
                        "text": "Site Pharmacy Operations Manager"
                    },
                    {
                        "text": "Usage of Potassium Chloride ampoules"
                    },
                    {
                        "text": "Trace of issues from pharmacy"
                    },
                    {
                        "text": "Department of Pharmacy"
                    },
                    {
                        "text": "Annual"
                    },
                    {
                        "text": "Medicines Assurance Group Divisional Governance Groups"
                    },
                    {
                        "text": "Medicines Assurance Group"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 22.0,
                "text": "Approval and implementation"
            },
            "type": "ListItem",
            "sequence_num": 332
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 22.1,
                "text": "All policies, procedures and guidelines will be approved by the Medicines Assurance Group, which is the specialist group with the authority to approve local medication documents. These will then be forwarded to the Document control team for submission and ratification by the Joint Document Management Group."
            },
            "type": "ListItem",
            "sequence_num": 333
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 22.2,
                "text": "It is the author's responsibility to inform the target audience of the approved policy documents when they are uploaded to the Trust's Intranets."
            },
            "type": "ListItem",
            "sequence_num": 334
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 23.0,
                "text": "Preliminary equality analysis"
            },
            "type": "ListItem",
            "sequence_num": 335
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 23.1,
                "text": "The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals. (Refer to appendix 1)"
            },
            "type": "ListItem",
            "sequence_num": 336
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 24.0,
                "text": "References"
            },
            "type": "ListItem",
            "sequence_num": 337
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All legacy National Patient Safety Agency alerts are available via the NHS England archive available at https://www.england.nhs.uk/patient-safety/patient-safety-alerts/  Locally held copies are kept by the Trust Medication Safety Officer."
            },
            "type": "ListItem",
            "sequence_num": 338
        },
        {
            "data": {
                "is_heading": 0,
                "text": "National Patient Safety Agency (2002). Patient Safety Alert: Potassium solutions: Risks to patients from errors during intravenous administration. Online at [ARCHIVED CONTENT] Potassium solutions: risks to patients from errors occurring during intravenous administration (nationalarchives.gov.uk) [Accessed 6.12.21]"
            },
            "type": "ListItem",
            "sequence_num": 339
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NHS Improvement (2021).  Never Events List 2018 (updated 02.2021) Online at 2018-Never-Events-List-updated-February-2021.pdf (england.nhs.uk)  [Accessed 6.12.21]"
            },
            "type": "ListItem",
            "sequence_num": 340
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NHS Medusa Injectable Medicines Guide (2021) Potassium Chloride IV monograph. Online at https://medusa.wales.nhs.uk [Accessed 25/11/2021] (All staff can access this resource freely of charge via all site intranets)."
            },
            "type": "ListItem",
            "sequence_num": 341
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Royal Pharmaceutical Society (2021). Medicines Ethics and Practice. Online at https://www.rpharms.com/publications/the-mep  [Accessed 21.11.2021] (Registered Pharmacists can access this resource freely of charge if members)."
            },
            "type": "ListItem",
            "sequence_num": 342
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Royal Pharmaceutical Society (2018). Professional guidance on the safe and secure handling of medicines. Online at https://www.rpharms.com/recognition/setting-professional-standards/safe-and- secure-handling-of-medicines/professional-guidance-on-the-safe-and-secure- handling-of-medicines  [Accessed 25.11.2021]"
            },
            "type": "ListItem",
            "sequence_num": 343
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Safe handling of medicines policy/MSEPO-21206/1.0"
            },
            "type": "ListItem",
            "sequence_num": 344
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 29.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 345
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Safe handling of medicines policy/MSEPO-21206/1.0"
            },
            "type": "ListItem",
            "sequence_num": 346
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix1: Preliminary equality analysis"
            },
            "type": "ListItem",
            "sequence_num": 347
        },
        {
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to:  Safe handling of medicines policy (Please tick all that apply)"
            },
            "type": "ListItem",
            "sequence_num": 348
        },
        {
            "type": "table",
            "sequence_num": 349,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2610 A change to an existing document"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2612 A new document"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 350,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Harmonisation of handling of medicines items"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "To align practice across all sites into single document"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Staff and patients as same requirements in place \u2013 consistency"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No. harmonising practice"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "Refer to pages 1 and 2."
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 351,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Richard Ketley"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Medication Safety Officer"
                    },
                    {
                        "text": "26 November 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 28.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 352
        }
    ]
}